BARDA tapped a team of Fred Hutch Cancer Center biostatisticians to determine the biomarkers that will serve as predictors of ...

Data from the largest US Lyme disease registry suggests that 90% of PLD patients are excluded from clinical trials.

On December 5, 2024, the U.S. Food and Drug Administration (FDA or Agency) issued a draft guidance entitled Expedited Program for ...

Amid recent backlash stemming from market withdrawals and trial delays, the FDA seeks to further clarify its requirements for ...

Xeltis announced today that it completed enrollment in an EU pivotal trial for aXess, its restorative vascular access conduit ...

Denali Therapeutics has reported that its Phase II/III HEALEY ALS Platform trial of DNL343 for ALS failed to meet its primary endpoint.

Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the ...

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

Age is an issue of mind over matter — h/t Mark Twain — but early ALS clinical trial results from Google-backed aging-disease ...

Delhi police on Tuesday argued in the Delhi High Court that February 2020 riots were a result of “clinical and pathological conspiracy” executed with a “diabolical intention and ruthless intensity”.

Act (UAPA), the Delhi Police opposed the bail of Sharjeel Imam, Umar Khalid, and others accused in the case involving the ...

After completing Yale SOM’s MBA for Executives program, Alicia Hardy ’23, Amaziah Coleman ’24, and Steven Starks ’23 returned to their workplaces with proposals to make quality healthcare more ...